The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Erythrodermic Psoriasis

Severe and life-threatening generalized inflammatory variant of psoriasis affecting more than 75-90% of body surface area.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Dermatoloji department. Book Appointment →

What is Erythrodermic Psoriasis?

Erythrodermic psoriasis (EP) is defined as generalized erythema covering ≥75-90% of body surface area with associated psoriatic features. It can develop de novo or as a complication of preexisting plaque psoriasis, often triggered by abrupt corticosteroid withdrawal, infections, drug reactions, phototherapy burns or systemic illness.

Pathophysiology involves intense Th17/Th1 immune dysregulation with massive cytokine release (IL-17, IL-23, TNF-alpha) leading to widespread cutaneous inflammation. Loss of skin barrier function causes thermoregulation failure, fluid and electrolyte imbalance, protein loss and increased risk of secondary infection and high-output cardiac failure.

Clinical features include diffuse fiery erythema, fine scaling, edema, lymphadenopathy, fever, chills, tachycardia and hypotension. Complications include sepsis, dehydration, hypoalbuminemia, anemia, acute kidney injury and venous thromboembolism. Treatment requires hospitalization, supportive care (fluid/electrolyte management, temperature regulation, nutrition) and rapid systemic therapy. Cyclosporine and infliximab are first-line for fast control; long-term management with IL-17 (secukinumab, ixekizumab) or IL-23 (guselkumab, risankizumab) inhibitors is preferred.

Symptoms

Generalized erythema covering >75-90% body surface
Diffuse fine scaling rather than thick plaques
Severe pruritus and burning sensation
Edema (especially lower extremities)
Fever, chills and rigors
Tachycardia and hypotension
Generalized lymphadenopathy
Nail dystrophy and severe scalp involvement

Risk Factors

Preexisting unstable plaque psoriasis
Abrupt withdrawal of systemic corticosteroids
Infections (streptococcal, HIV)
Drug reactions (lithium, antimalarials, beta-blockers)
Phototherapy burns or sunburn
Severe psychological stress
Alcohol abuse
Underlying systemic illness

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Sudden generalized redness and scaling — emergency
  • Fever with widespread skin involvement
  • Hypotension or tachycardia with skin disease
  • Known psoriasis with rapid extensive flare
  • Failure of outpatient therapy
  • Signs of sepsis or systemic toxicity
  • Dehydration or electrolyte imbalance
  • Suspected drug-induced erythroderma

Treatment Methods

01
Hospitalization and supportive care (IV fluids, nutrition)
02
Temperature regulation and skin barrier protection (emollients, wet wraps)
03
Cyclosporine 3-5 mg/kg/day for rapid control
04
Infliximab 5 mg/kg IV at weeks 0-2-6 then every 8 weeks
05
IL-17 inhibitors (secukinumab, ixekizumab) for long-term control
06
IL-23 inhibitors (guselkumab, risankizumab) as alternative
07
Avoidance of systemic corticosteroids (rebound risk)
08
Treatment of triggering infections and drug review

Which Department to Visit?

You can visit our Dermatoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Dermatoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Eczema (Atopic Dermatitis)

Dermatoloji

Atopic dermatitis is a chronic skin disease commonly seen especially in children, flaring with genetic predisposition and environmental triggers.

Psoriasis

Dermatoloji

Psoriasis is an autoimmune disease in which skin cells proliferate rapidly when the immune system mistakenly attacks the skin, leading to thick scaly lesions.

Acne

Dermatoloji

Acne is a skin disease resulting from clogging of hair follicles with oil and dead skin cells, commonly seen in adolescence but can occur at any age.

Rosacea

Dermatoloji

Rosacea is a chronic inflammatory facial skin disease characterized by recurrent flushing, persistent erythema, telangiectasia, and inflammatory papules and pustules. Phymatous change and ocular involvement may complicate advanced disease.

Urticaria (Hives)

Dermatoloji

Urticaria is a skin condition with sudden pink-red wheals and intense itching that may follow an acute or chronic course.

Skin Fungal Infections

Dermatoloji

Skin fungal infections are common, contagious skin diseases caused by dermatophytes and yeast fungi colonizing the upper layers of the skin.

Hair Loss (Alopecia)

Dermatoloji

Alopecia is a general term for hair loss that can be genetic, hormonal, autoimmune, or nutritional; early intervention can slow progression.

Vitiligo

Dermatoloji

Vitiligo is an acquired autoimmune disease in which CD8+ T cells destroy melanocytes, producing well-demarcated depigmented patches. Early, sustained treatment can induce repigmentation and prevent progression; psychosocial impact warrants holistic care.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.